When did VITEK 2 AST-Streptococcus Cefuroxime ( =8 µg/mL) receive FDA 510(k) clearance?

VITEK 2 AST-Streptococcus Cefuroxime ( =8 µg/mL) received FDA 510(k) clearance on 2026-03-26, under 510(k) number K260281.

FDA 510(k)

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)

K-번호: K260281 · 2026-03-26

신청자BIOMERIEUX

결정일2026-03-26

제품 코드LON

자문 위원회MI

결정Substantially Equivalent

기기 요약

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) is the device name listed in this FDA 510(k) record. The listed applicant is BIOMERIEUX. It received FDA 510(k) clearance on 2026-03-26 under 510(k) number K260281. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

자주 묻는 질문

What is the VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)?

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) is a medical device that received FDA 510(k) clearance on 2026-03-26. The listed applicant is BIOMERIEUX. The 510(k) number is K260281.

When did VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) receive FDA 510(k) clearance?

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) received FDA 510(k) clearance on 2026-03-26, under 510(k) number K260281.

Who is the listed applicant for VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)?

The FDA 510(k) record lists BIOMERIEUX as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)?

The FDA product code for VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) is LON.

공식 출처

FDA 데이터베이스에서 보기 →

FDA Open API에서 수집된 데이터입니다. 가장 정확하고 공인된 정보는 항상 공식 레코드를 참조하시기 바랍니다.

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)

기기 요약

자주 묻는 질문

관련 임상시험

관련 기기 (코드: LON)

공식 출처